0XU

(2S,5S,6E)-2,5-diamino-6-[(3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene]hexanoic acid

Created:	2012-09-04
Last modified:	2012-10-12

Find Related PDB Entry
1 entries where 0XU is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	48
Chiral Atom Count	5
Bond Count	50
Aromatic Bond Count	10

2D diagram of 0XU

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	(2S,5S,6E)-2,5-diamino-6-[(3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxydihydrofuran-2(3H)-ylidene]hexanoic acid
Systematic Name (OpenEye OEToolkits)	(2S,5S,6E)-6-[(3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-ylidene]-2,5-bis(azanyl)hexanoic acid
Formula	C₁₅ H₂₁ N₇ O₅
Molecular Weight	379.371
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)C(N)CCC(N)\C=C3\OC(n2cnc1c(ncnc12)N)C(O)C3O
SMILES	CACTVS	3.370	N[CH](CC[CH](N)C(O)=O)C=C1O[CH]([CH](O)[CH]1O)n2cnc3c(N)ncnc23
SMILES	OpenEye OEToolkits	1.7.6	c1nc(c2c(n1)n(cn2)C3C(C(C(=CC(CCC(C(=O)O)N)N)O3)O)O)N
Canonical SMILES	CACTVS	3.370	N[C@@H](CC[C@H](N)C(O)=O)\C=C1\O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)ncnc23
Canonical SMILES	OpenEye OEToolkits	1.7.6	c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H](/C(=C\[C@H](CC[C@@H](C(=O)O)N)N)/O3)O)O)N
InChI	InChI	1.03	InChI=1S/C15H21N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h3-7,10-11,14,23-24H,1-2,16-17H2,(H,25,26)(H2,18,19,20)/b8-3+/t6-,7-,10+,11+,14+/m0/s1
InChIKey	InChI	1.03	YNKCTZQHSHSLNN-XVIGKWCNSA-N

Related Resource References

Resource Name	Reference
PubChem	60210984

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.